Yaniv Berger, DO
Family Medicine · Baltimore, MDNPI 1992962369
Payments from drug & device makers
Across 790 payments — averaging $16.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Novo Nordisk$2K
- AstraZeneca$1K
- Lilly USA, LLC$1K
- Amgen$1K
- Bayer$617
- plus $4K from 44 others
What the payments were for
- Consulting fees$1201%
- Food & beverage$12,59697%
- Education$2412%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,957 in reported general payments places this provider in the 95th percentile of 1,193 family medicine providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 137 | $123,916 |
| OzempicSemaglutide | 88 | $112,995 |
| MounjaroTirzepatide | 68 | $90,274 |
| JardianceEmpagliflozin | 107 | $87,315 |
| FarxigaDapagliflozin Propanediol | 73 | $81,376 |
| RybelsusSemaglutide | 38 | $67,195 |
| TrulicityDulaglutide | 35 | $50,889 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 20 | $34,660 |
| KerendiaFinerenone | 36 | $29,193 |
| XareltoRivaroxaban | 19 | $29,064 |
| Tresiba Flextouch U-200Insulin Degludec | 25 | $27,056 |
| JanuviaSitagliptin Phosphate | 18 | $23,980 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 20 | $14,069 |
| Xigduo XrDapaglifloz Propaned/Metformin | 12 | $10,794 |
| DapagliflozinDapagliflozin Propanediol | 13 | $10,339 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $2,027 | $180,190126 claims |
| Lilly USA, LLCMounjaro, Trulicity | $1,283 | $141,163103 claims |
| PfizerEliquis | $524 | $123,916137 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $1,487 | $89,09485 claims |
| Boehringer IngelheimJardiance | $553 | $87,315107 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $317 | $34,66020 claims |
| BayerKerendia | $617 | $29,19336 claims |
| Johnson & JohnsonXarelto | $32 | $29,06419 claims |
| MerckJanuvia | $232 | $23,98018 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $447 | $23,35532 claims |
| AbbVieLinzess | $2,031 | $9,41214 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,193 family medicine providers in Maryland.
Other family medicine in Baltimore
- Karen DonaldsonBaltimore$899K
- Louis JacquesBaltimore$522K
- Michael ObiefuneBaltimore$291K
- Daljeet SalujaBaltimore$63K
- Fernando PorterBaltimore$54K
- Richard ColganBaltimore$31K
- Stacy GarrettBaltimore$20K
- Nishant ShahBaltimore$17K
- Diaa MikhailBaltimore$15K
- Stephen OngOxon Hill$5.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.